Mersana Therapeutics Inc.
Clinical‑stage biopharma Mersana Therapeutics focuses on antibody‑drug conjugates for unmet‑need cancers, with Phase‑I B7‑H4 and HER2 ADCs and strategic collaborations with Janssen, Merck and Asana Biosciences.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 102
- HQ: Cambridge
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.